Sign In / Register
Make This My Home Page | Feedback |RSS
You are here: IE »   Story

Gates gives $168 mln for malaria vaccines research

  • Print
  • Mail This Article
  • Comments
  • Add to favorites
  • Bill Gates gave $168.7 million to develop vaccines for malaria.

    The World Bank said on Thursday it will increase spending on fighting malaria in Africa by $1.1 billion, and focus on the Democratic Republic of Congo and Nigeria, which account for 30 percent to 40 percent of all malaria deaths worldwide.

    World Bank President Robert Zoellick said countries such as Ethiopia, Rwanda, and Zambia had made progress in cutting malaria deaths through the distribution of bed nets and more access to low-cost, effective drugs for treating the disease.

    In other funding announced, the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria said it would give $1.62 billion in grants over the next two years for malaria; Britain pledged $40 million; and Houston-based Marathon Oil pledged $28 million for Equatorial Guinea over five years. Meanwhile, the U.N. High Commissioner for Refugees said it would give $2 million for insecticide-treated bed nets to refugees in Africa.

    Ads by Google

    Previous12
    Comments
    Post comment

    Be the first to comment.

    Post a Comment
    Name:
    Email:
    Title:
    Maximum characters allowed     
    Comment:
    TERMS OF USE:
    The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
    I agree to the terms of use.